IDweek2023 | The Revolutionary Shift in HIV Management: An In-Depth Analysis of Cabotegravir + Rilpivirine Long-Acting Treatment Versus Traditional Oral Antiretroviral Therapy

IDweek2023 | The Revolutionary Shift in HIV Management: An In-Depth Analysis of Cabotegravir + Rilpivirine Long-Acting Treatment Versus Traditional Oral Antiretroviral Therapy

2023.10.27
IDweek2023 The Revolutionary Shift in HIV Management: An In-Depth Analysis of Cabotegravir + Rilpivirine Long-Acting Treatment Versus Traditional Oral Antiretroviral Therapy In the ever-evolving world of medicine, the ultimate goal has consistently been to enhance patient adherence and improve treatment outcomes. This is particularly apparent in the management of HIV, where antiretroviral therapy (ART) has been the cornerstone of treatment for many years. However, with the development of long-acting ART, there has been a dramatic shift in the landscape of HIV management. This comprehensive article delves into a detailed analysis of the real-world adherence and persistence of Cabotegravir + Rilpivirine Long-Acting (CAB+RPV LA) compared to oral ART among people living with HIV (PWH) in the United States. This analysis is based on the ABOVE Study, conducted by a team of researchers and healthcare professionals from ViiV Healthcare and Analysis Group, Inc.
IDweek2023 | A Deep Dive into the Real-World Use of Long-Acting Cabotegravir + Rilpivirine in People with HIV with Detectable Viral Loads at Initiation: Insights from the OPERA® Cohort.

IDweek2023 | A Deep Dive into the Real-World Use of Long-Acting Cabotegravir + Rilpivirine in People with HIV with Detectable Viral Loads at Initiation: Insights from the OPERA® Cohort.

2023.10.27
IDweek2023 A Deep Dive into the Real-World Use of Long-Acting Cabotegravir + Rilpivirine in People with HIV with Detectable Viral Loads at Initiation: Insights from the OPERA® Cohort. The world of HIV (Human Immunodeficiency Virus) management has seen remarkable strides over the years, with the advent of antiretroviral therapy (ART) significantly improving the quality of life for people living with the virus. One of the groundbreaking developments in this field is the emergence of long-acting injectable antiretroviral regimens, offering a unique approach to maintaining viral suppression and alleviating the burden of daily oral medication.